Introduction
Bartonella bacilliformis , a Gram-negative bacterium and the causative agent of Carrion's disease (bartonellosis), is transmitted to humans by the bite of an insect vector. Bartonella bacilliformis initially parasitizes erythrocytes (in the phase of the disease called Oroya fever) and subsequently invades vascular endothelial cells (in the phase of the disease called verruga peruana) (Schultz, 1968) . Bartonella bacilliformis invasion of endothelial cells leads to pronounced endothelial cell proliferation, angiogenesis and formation of haemangiomatous dermal eruptions (verrugas) . Similar lesions are seen in bacillary angiomatosis, which occurs in immunocompromised patients infected with Bartonella henselae (Tappero et al ., 1993) .
Little is known about the mechanism of entry of B. bacilliformis into endothelial cells or the events that follow. In vitro , Bartonella spp., enter many cell types, including fibroblast, laryngeal epithelial and human endothelial cells. Inhibition of entry by cytochalasin D suggested that the host cell actively participates in the invasion process and that the bacteria enter by a microfilament-dependent process similar to phagocytosis (Hill et al ., 1992) . Bartonella henselae are transported by the leading lamella of the endothelial cell and then are engulfed by fusion of membrane protrusions over a period of about 24 h in vitro (Dehio et al ., 1997) . In previous studies, we observed that cells infected with B. bacilliformis became spindle-shaped and contained arrays of actin stress fibres oriented parallel to the long axis of the cell. The stress fibres terminated in an increased number of focal adhesions. Cell-cell contacts were disrupted, with loss of PECAM-1, which participates in cell-cell junctions (Verma et al ., 2001 ). Rho, a key signalling protein in pathways involving actin organization, has been directly shown to be activated in endothelial cells undergoing infection with B. bacilliformis , with maximal activation and translocation to the plasma membrane at 12-16 h (Verma et al ., 2000) .
The actin cytoskeleton is a highly dynamic structure involved in various cellular functions including maintenance of cell integrity, induction of morphological changes, motility and endocytosis. These functions are exploited by bacterial and viral pathogens to promote their entry into the mammalian cells (Finlay and Cossart, 1997) . Listeria , Yersinia and Neisseria enter by binding to host cell receptors that function as part of the endocytosis system (Ireton and Cossart, 1998) . Some pathogenic bacteria inject virulence factors using Type III or Type IV transport systems. Virulence proteins injected by Salmonella and Shigella produce membrane ruffling and actin rearrangements at the cell surface that facilitate bacterial uptake.
The small GTP-binding proteins of the Rho family (Rho, Rac and Cdc42) are key regulators of the actin cytoskeleton. They cycle between an inactive state with bound GDP and an active state with bound GTP, which transmits informational signals to specific downstream effector molecules. Rho controls the formation of stress fibres, focal contacts and cell contractility , Cdc42 generates filamentous actin extensions called filopodia (Kozma et al ., 1995; Nobes and Hall, 1995) and Rac promotes the formation of membrane ruffling known as lamellipodia . Rac and Cdc42, in addition to Rho, are involved in the regulation of cellular processes involving organization of the actin cytoskeleton, focal adhesions, cytokinesis and response to nuclear and mitogenic signalling agents (Coso et al. , 1995; Minden et al ., 1995; Hall, 1998) and some pathways involving Rac and Cdc42 have been elucidated (Chong et al ., 1994; Hartwig et al ., 1995) . Putative effector proteins have been identified that directly interact with activated (GTP-bound) Rac and Cdc42 (Hart et al ., 1996; Symons et al ., 1996; Teramoto et al ., 1996) . A direct target for active Rac has been identified as a family of serine/threonine kinases known as p21-activated kinases or PAKs (Manser et al ., 1994; Bagrodia et al ., 1995a; Knaus et al ., 1995) , whose activity is stimulated by the binding of GTP-bound Rac and Cdc42.
Several bacterial protein toxins ( Escherichia coli cytotoxic necrotizing factor, CNF1; dermonecrotic toxin, DNT from Bordetella pertussis ) are known to activate selectively Rho-family GTPases. Other toxins (C3 exoenzyme from Clostridium botulinum , toxin A and B from Clostridium difficile and lethal toxin from Clostridium sordellii ) inactivate Rho-family GTPases by ADP-ribosylation and glucosylation (Lerm et al . 2000) . The existence of these toxins suggests the importance of Rho-family GTPases in the infectious process. These toxins have been used to elucidate the role of Rho-family GTPases in the control of various cellular processes by inhibition of the activity of different Rho-GTPases. Previously, we demonstrated that incubation with C3 exoenzyme of endothelial cells infected by B. bacilliformis partially or completely prevented formation of stress fibres and increased focal adhesions. Preincubation of the endothelial cells with C3 exoenzyme before addition of the bacteria blocked internalization of the bacteria, and addition of C3 exoenzyme at any time after infection blocked further internalization of the bacteria (Verma et al ., 2000) .
PAKs have also been implicated in reorganization of the actin cytoskeleton, focal adhesion complexes and in the activation of a Rac/Cdc42-controlled kinase cascade leading to stimulation of the stress-activated mitogen-activated protein kinases (MAPK), p38 and c-Jun NH2-terminal kinase (JNK) (Bagrodia et al ., 1995b; Zhang et al ., 1995) . The response of eukaryotic cells to extracellular signals can involve the activation of the family of MAPKs including a subfamily, the stress-activated protein kinases (SAPK), that are activated by multiple environmental stresses. These target the transcription factors c-Jun and ATF2, which are the components of the transcription factor, AP-1 (Karin et al ., 1997) . Proteins under the control of AP-1 and nuclear factor NF-κ B include those responsible for the proinflammatory cytokines such as IL-8. In many cell types, Rho, Rac and Cdc42 are part of an interconnected signalling pathway and become activated by a hierarchical cascade in which Cdc42 activates Rac, which in turn activates Rho, resulting in specific cytoskeletal rearrangements.
In this study, we examined the formation of filopodia and lamellipodia (known to be under the control of Rac and Cdc42), in endothelial cells infected with B. bacilliformis . Rac and Cdc42 were activated by B. bacilliformis infection and protein toxins known to inactivate these GTPases blocked bacterial activation of Rac and Cdc42. In addition the activation of several downstream effectors of Rhofamily GTPases was demonstrated.
Results

Formation of filopodia, membrane ruffles and recruitment of Rac, to the membrane ruffles are early events in infection by B. bacilliformis
In our earlier studies, we examined the extensive cytoskeletal remodelling that occurs in endothelial cells after infection with B. bacilliformis and demonstrated the involvement of activated Rho-GTPase in this process and in the internalization of the bacteria. In this report, we demonstrate the participation of Rac-and Cdc42-GTPases in infection and cytoskeletal changes in endothelial cells.
The actin cytoskeleton of endothelial cells was examined for indications of cytoskeletal rearrangement occurring at very early times (0-1 h) after addition of the bacteria. Uninfected and infected endothelial cells were stained with F-actin phalloidin-fluorescin and the antibodies to Rac and Cdc42. In uninfected cells, phalloidin-fluorescin staining shows a haphazard F-actin arrangement whereas Cdc42 (Fig. 1A) and Rac (Fig. 1E ) staining were restricted to the perinuclear region. Fluores-cence microscopy of semiconfluent infected endothelial cells stained with F-actin phalloidin-fluorescin demonstrated formation of small actin filamentous structures originating from the endothelial cells within 15 min after infection. After 30 min, prominent thin F-actin microspikelike structures (filopodia) were clearly visible (Fig. 1B) . Polymerization of F-actin was clearly evident at the periphery of the infected endothelial cells. Within 1 h of infection, extensive membrane ruffles (lamellipodia-like structures) associated with F-actin accumulation were seen (Fig. 1F) . Formation of filopodia and membrane ruffles increased with time of infection. Clumps of green fluorescent bacteria were also observed adhering or in the close vicinity to these filopodia and membrane ruffles, at a time when few intracellular bacteria were seen. Double staining of infected endothelial cells with F-actin phalloidin and monoclonal antibodies directed against individual Rho-GTPases, Cdc42 and Rac were also performed to examine the recruitment of these RhoGTPases to the actin structures (filopodia and membrane ruffles) induced by B. bacilliformis infection in endothelial cells. Overlay of images stained with F-actin and Cdc42 did not show co-localization or recruitment of Cdc42 to the filopodia or to the region of actin polymerization (Fig. 1B-D) . In contrast, an intense co-localization of Rac and polymerized F-actin was clearly observed in the membrane ruffles, in addition to its perinuclear localization ( Fig. 1F-H) .
Activation of Rac/Cdc42 in endothelial cells infected with B. bacilliformis
In many cell types activation of Cdc42 induces the formation of filopodia and activation of Rac leads to the formation of lamellipodia and membrane ruffles Nobes and Hall, 1995) . In our study, formation of filopodia and membrane ruffles prompted us to investigate whether Cdc42 and/or Rac are activated by B. bacilliformis infection of endothelial cells. Activated Cdc42 and Rac were affinity precipitated with GST-PBD (p21-activated kinase binding domain for activated Cdc42 and Rac) as described in Experimental procedures . Western blot analysis of GST-PBD bound proteins precipitated using respective antibodies against Cdc42 or Rac, showed a 3.4-5.0-fold increase in activated Cdc42 and Rac. The increase in activated Rac and Cdc42 was timedependent, but biphasic, with an initial increase at 30 min to 1 h and a later increase at 8-12 h after initiation of infection ( Fig. 2A and B) . Levels of total Rac and Cdc42 were also determined in infected and uninfected endothelial cells. There was no substantial increase in levels of total Rac and Cdc42 in infected cells, either with time, or in comparison with uninfected cells. Western blotting with anti-GAPDH antibodies with the total proteins blots was also performed to demonstrate equal loading of the proteins throughout the infection process.
Involvement of Rac/Cdc42 in internalization of B. bacilliformis in endothelial cells
To further investigate whether activation of Rac and/or Cdc42 is required for internalization of B. bacilliformis , endothelial cells were incubated with Clostridial toxins that inactivate Rho-family GTPases by glucosylation. Toxin TcdB-10463 inactivates all three Rho-GTPases, Rho, Rac and Cdc42 (von Eichel-Streiber et al ., 1996) . TcsL-1522 primarily modifies Rac but also Cdc42 to a lesser extent (Just et al ., 1996; Popoff et al ., 1996) . The cytotoxic dose required for cell rounding was determined for endothelial cells by serial dilution of each toxin. TcdB-10463 at 1 µ g ml − 1 caused 100% rounding in 4 h and TcsL-1522 at 100 ng ml − 1 resulted in 100% rounding in 24 h. The level of Rho-GTPases not glucosylated in vivo by these toxins was determined in vitro by incubating toxin treated cell extracts with the same toxin and UDP-[ ) for 1, 2, 3 and 4 h and with TcsL-1522 (100 ng ml − 1 ) for 4, 8, 12, 16 and 24 h showed increased in vivo glucosylation. A decrease in the signal intensity of the in vitro glucosylated Rho-GTPases indicates increased glucosylation in vivo of these GTPases by toxins ( Fig. 3A and B) .
The ability of B. bacilliformis to invade cells preincubated with Clostridial toxins for various lengths of time was determined using flow cytometic analysis after a 2 h incubation with fluorescent bacteria as described previously (Verma et al ., 2000) . A dramatic and progressive decrease in the percentage of infected cells pretreated with TcdB-10463 (1 µ g ml − 1 ) for 1-4 h was observed, in parallel with the decrease in non-glucosylated RhoGTPases (Fig. 3A) . A similar, but less pronounced, progressive decrease in the percentage of infected cells pretreated with TcsL-1522 (100 ng ml − 1 ) for 4-24 h also occurred in parallel with the decrease in non-glucosylated Rho-GTPases (Fig. 3B) . Nearly complete inhibition of entry, when all three members of the family of RhoGTPases (Rho, Rac and Cdc42) are inactivated (80-90%), demonstrates the involvement of Rho-family GTPases in the entry process (Fig. 3A) . A partial but steady decrease (30-40%) in the percentage of infected cell was observed with increasing time of treatment with the toxin TcsL-1522 (Fig. 3B) . We attempted to use the C. difficle toxin B (TcdB 1470) which strongly inhibits Rac and also Cdc42 to a significant extent (Muller et al ., 1999) , but the toxin preparation had neither a cytotoxic effect nor in vivo glucosylating activity in the endothelial cells. However, the same toxin preparation was potent and active on NIH 3T3 cells. The resulting decrease in internalization of B. bacilliformis caused by inactivation of RhoGTPases by toxins suggests active involvement of these small proteins in the cytoskeletal alterations (filopodia and membrane ruffling), which are ultimately involved in the internalization process.
Increased levels of p21-activated kinase activity after infection with B. bacilliformis
Activated Cdc42 and Rac (with bound GTP) interact specifically with PAKs (Manser et al., 1994; Knaus et al., 1995) . To investigate whether activation of Rac and Cdc42 during Bartonella infection triggers the activation of the downstream effector PAK, the kinase activity of PAK was assessed. The activity of a direct downstream target for activated Cdc42/Rac, PAK1, was assessed in vitro using anti-PAK1 antibody to precipitate an immunocomplex for the kinase assay. Increased (2.3-fold) PAK1 activity was detected at 1 h after addition of the bacteria compared with the kinase activity of uninfected endothelial cells. PAK1 activity then decreased at 2 and 4 h after infection, but by 12 h maximal kinase activity (2.5-fold increase) was observed ( Fig. 4) with again a decline at 24 h. PAK activity also followed a biphasic pattern as observed with the infection process as well. Western blot analysis of total proteins from the infected and uninfected endothelial cells with anti-PAK antibodies showed increased expression up to 4 h after initiation of infection. By 12-24 h, however, the level of PAK protein in the total lysates decreased dramatically. Levels of GAPDH were constant over these time periods. Consequently it would appear that the activity is maximal at a time when relatively little protein was present.
B. bacilliformis-induced activation of transcription factor AP-1 and phosphorylation of SAPK/JNK 1 and 2
Activation of Rac, Cdc42 and phosphorylation of PAK led us to investigate whether B. bacilliformis infection activates the transcription factors AP-1 and NF-κB. Monolayers of endothelial cells were infected with B. bacilliformis for different time periods (30 min, 1, 2, 4, 8, 12, 16 and 24 h). Nuclear protein extracts were prepared and analysed for the levels of cellular AP-1 and NF-kB DNA binding activity by electrophoretic mobility shift assay (EMSA) using a radiolabelled oligonucleotide corresponding to the AP-1 and NF-κB DNA binding site. As shown in Fig. 5A and B, increased binding of AP-1 was observed within 30 min after infection (approximately threefold increase) and remained elevated (2.5-2.0-fold increase relative to DNA binding activity of uninfected endothelial cells), with a maximal activity at 8 h after infection (3.8-fold increase). Specificity of the AP-1 DNA binding activity induced by B. bacilliformis was determined using non-radiolabelled specific competitors (AP-1 oligonucleotide, Fig. 5A , lane SPI) and non-specific competitor, NF-κB oligonucleotide (Fig. 5A, lane NSPI) .
No increase in DNA binding was observed for NF-κB transcription factor at different time periods of infection (data not shown). However, we note that B. henselae has been reported to activate NF-κB (Fuhrmann et al. 2001) .
AP-1 transcription factor is not a single transcription factor, but instead a series of related dimeric complexes of Fos and Jun family proteins. Phosphorylation and activation of c-Jun occur by JNKs in N-terminally located transactivation domains and results in increased transcriptional activity. It is clear from our results that there is an increased phosphorylation of c-Jun during the course of B. bacilliformis infection, with a maximum phosphorylation (4.0-4.5-fold) at 16-24 h as opposed to the moderate level of total c-Jun protein throughout the infection (Fig. 5B) . The transcription factor AP-1 is activated by phosphorylation of c-Jun by members of stress activated MAPK (SAPK) family in response to environmental stress (Karin et al., 1997) . Therefore, we have examined whether the SAPK/JNK 1 and 2, and/or p38 MAPK are involved in the signalling events leading to B. bacilliformis induced AP-1 (Fig. 6A) . Immunoblotting of the same blot with total SAPK /JNK antibody showed almost equal loading of the protein. In parallel, up to a fourfold increase and sustained phosphorylation of p38 MAPK was also observed using the phosphospecific-antibodies to these MAPKs (Fig. 6B) with the increase in time of infection.
Discussion
The experiments on Rac and Cdc42 reported here, supported by previous work on Rho (Verma et al. 2000; , demonstrate that infection by B. bacilliformis activates Rho-family GTPases (Rho, Rac and Cdc42) and suggest that B. bacilliformis stimulates its own entry into endothelial cells by activating Rho-, Rac-and Cdc42-dependent signalling pathways. Rac is known to promote the formation of lamellipodia, whereas Cdc42 is known to generate filopodia (Nobes and Hall, 1995) . Within 15-30 min after addition of the bacteria, increased numbers of filopodia were seen at the endothelial cell surface. Within 1 h after initiation of infection, the filamentous structures disappeared and lamellipodia were seen. , 16 and 24 h) were analysed for the binding activity in a gel retardation assay using 32 P-labelled AP-1 binding site oligonucleotide as a probe. The arrow indicates the shifted complex and arrowhead represents the free probe. The specificity of the shifted complex was analysed with the cold oligonucleotide competition. SPI is specific inhibitor (100-fold cold AP-1 oligonucleotide) and NSPI is the non-specific inhibitor (100-fold cold NF-κB oligonucleotide). B. Quantification of the gel shifts assay was performed on phosphoimager and is indicated as fold increase activity against the control. C. Total cell lysates from the endothelial cells infected with B. bacilliformis for 30 min, 1, 2, 4, 8, 12, 16 and 24 h were separated on SDS-PAGE, blotted and probed with the phospho-c-Jun and total c-Jun antibodies. Equal loading of the protein samples were confirmed by probing the blot with anti-GAPDH antibodies. D. Quantification of the Western blot was performed on phosphoimager and is indicated as fold increase of phosphoc-Jun (black bars) in relation to the total c-Jun (hatched bars) at the different times of infection Clumps of bacteria on the surface of the endothelial cells were seen in close association with the filopodia and lamellipodia.
At the same time, within 30 min of infection, levels of both activated Rac and Cdc42 were increased and they remained elevated throughout the infection compared with the levels of Rac and Cdc42 in uninfected cells. Overlay of fluorescence images stained with F-actin phalloidin and monoclonal antibodies directed against these GTPases demonstrated co-localization of actin and Rac (but not Cdc42) in lamellipodia-like structures.
Additional evidence for the involvement of Rho-family GTPases in infection was obtained using toxins that are known to inactivate Rho-GTPases. Previously, it was shown that preincubation of endothelial cells with C3 exoenzyme, which inactivates Rho, blocked subsequent internalization of the bacteria and, if added before the bacteria, prevented infection (Verma et al., 2000) . In the experiments reported here, large C. difficile toxin B (TcdB-10463) and lethal toxin from C. sordellii (TcsL-1522) were used.
TcdB-10463 inactivates Rho, Rac and Cdc42 by glucosylation (von Eichel-Streiber et al., 1996) . Preincubation of the endothelial cells with this toxin inhibited internalization of B. bacilliformis into endothelial cells in a timedependent manner. Preincubation of endothelial cells for 1 h with TcdB-10463 followed by infection, led to a 50% decrease in the percentage of endothelial cells which were infected. When the endothelial cells were preincubated with the toxin for 4 h, at which time almost 90% of the Rho-GTPases were glucosylated (see Fig. 3 ), 70-80% inhibition was observed. As incubation of eukaryotic cells with C. difficile toxin B (TcdB-10463) leads to the complete disruption of the actin cytoskeleton, resulting in the rounding of the cells, it is not surprising that this toxin has a major effect on internalization.
Lethal toxin from C. sordellii (TcsL-1522) glucosylates Rac, and to a much lesser extent, Cdc42. Rho is not glucosylated by this toxin Just et al., 1996; Chaves-Olarte et al., 1999) . Preincubation of endothelial cells with TcsL-1522 resulted in a 30-40% decrease in the percentage of infected endothelial cells. This result would seem to implicate Rac/Cdc42 as being involved in the entry process. The decrease observed in the percentage of infected endothelial cells is perhaps more likely to be caused by the inactivation of Rac rather than Cdc42, because of the preference for Rac of lethal toxin from C. sordellii (TcsL-1522) . However the decrease observed is somewhat modest and so Cdc42 as the target cannot be ruled out.
These results suggest that invasion is mediated by host Rho-family GTPases, although they leave it uncertain as to whether entry requires activation of all three RhoGTPases, or whether activation of one or two of these proteins would be sufficient. Because of the interconnections between these pathways, activation of all three RhoGTPases might occur, even if the primary activity of B. bacilliformis is directed to only one or two of the RhoGTPases. Other pathogenic bacteria, including Shigella and Salmonella, are known to also activate Rho-family of GTPases (Nobes and Hall, 1995; Adam et al., 1996) .
As all three Rho-family GTPases are activated, the consequences of activation might extend to all cell functions controlled by these proteins. We have examined some of the proteins known to be activated by Rho-family GTPases and have found these downstream effector proteins are in fact activated. The activity of serine/threonine p21-activated kinase (PAK) is known to be increased by activated Rac and Cdc42 (Bagrodia et al., 1995a; Zhang et al., 1995) . Increased PAK activity was found within 1 h after addition of the bacteria and again at 12-24 h. Stress-activated protein kinases (SAPK/JNK 1 and 2 and p38/MAPK) were also activated. As PAK does not directly phosphorylate SAPK/JNK 1 and 2 and p38/ MAPK, this must be accomplished by some other intermediate and downstream signalling kinase (MAPKK and MAPKKK) which, in turn, phosphorylates SAPK/JNK and p38 MAPK and under the control of Rho-family GTPases.
Activation of SAPK/JNK is known to stimulate c-Jun phosphorylation. An increased binding activity of AP-1 (heterodimers of Jun and Fos family proteins) as a result of c-Jun phosphorylation was found to be associated with B. bacilliformis infection of endothelial cells.
These results indicate that a variety of intracellular signalling pathways are likely to be activated by B. bacilliformis infection, with resultant alterations in the synthesis of proteins at the transcriptional level. The final result of activation of Rho-family GTPases by B. bacilliformis might or might not correspond closely to the consequences of normal modes of intracellular signalling, but certainly it would have features similar to the response induced by environmental signals. For example, shear stress in endothelial cells induces activation and translocation of Cdc42 and Rho from cytosol to membrane, leads to activation of AP-1 and NF-kB (Lan et al., 1994) and expression of genes controlling growth factors, adhesion molecules, coagulation molecules, chemoattractants, proto-oncogenes and vasoactive substances. Hypoxia leads to increased AP-1 [and hypoxia-inducible factor 1 (HIF-1) activity] and expression of angiogenic factors in a Rac 1-, p38 MAPK-and c-Jun-dependent manner (Alfranca et al. 2002) .
Angiogenesis programmes are known to be switched on by VEGF and a key aspect of these programmes is activation of intracellular Rho and Rho-family proteins after binding of VEGF to its receptor (Gingras et al., 2000) . It seems likely that infection with B. bacilliformis will activate the entire VEGF programme, as there is good evidence that activation of Rho results in activation upstream as well as downstream, that the VEGF receptor becomes phosphorylated and activated by activated Rho and that it then stimulates the phosphorylation of intermediaries in the VEGF signalling cascade (Gingras et al., 2000) .
We conclude that B. bacilliformis, like other pathogenic bacteria, manipulates the host cell with a sophisticated finesse to enable and enhance bacterial entry into the cell. After activation of Rho, Rac and Cdc42, the host cell is stimulated to form filopodia and lamellipodia that serve to introduce the bacteria into the cell, as described by Dehio et al. (1997) . Activation of the Rho-family GTPases results in downstream signalling, eventually activating AP-1, a nuclear transcription factor.
Experimental procedures
Bacterial strains
Bartonella bacilliformis was routinely grown at 28°C in phosphate-buffered saline (PBS) over brain-heart infusion agar plates containing 10% defibrinated sheep blood (Dickinson Microbiology System, Cockeysville, MD) (Benson et al., 1986) . Bartonella bacilliformis expressing GFP (Dehio et al., 1997) prepared as described in Verma et al. (2000) was used in this study. Escherichia coli expressing the GST-PBD (P21 binding domain of PAK) cloned into pGEX expression vector system (Pharmacia Biotech, Inc.) was kindly provided by Dr J. E. Galán (Yale University, New Haven, Connecticut).
Antibodies and reagents
Mouse monoclonal antibodies directed against Rac and Cdc42 were obtained from Transduction Laboratories (Becton Dickinson Company, San Jose, CA). Mouse monoclonal antibody to glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was obtained from Research Diagnostics (USA). Rabbit polyclonal anti-PAK (alpha N-20) was from Santa Cruz Biotechnology. Rabbit antimouse HRP conjugate and rabbit anti-mouse IgG-TRITC were from DAKO. F-actin phalloidin was from Molecular Probes. ECL detection kit was purchased from Pharmacia. Myelin basic protein (MBP) was purchased from Sigma Corporation (St Louis, MO). Different Clostridial toxins, TcdB-10463 (C. difficile) and TcsL-1522 (C. sordellii ) were supplied from TGC Biomics (Germany). Phospho-p38 MAPK, phospho-SAPK/JNK and phospho-c-Jun were from Cell Signaling Technology (NEB).
Infection of human endothelial cells with B. bacilliformis
Human umbilical vein endothelial cells (HUVECs) (Clonetics, San Diego, CA) were propagated between passages two and seven. HUVECs were seeded on glass cover slips, tissue culture flasks and in six-well plates coated with gelatin (1 mg ml −1 ), in M199 containing 20% fetal bovine serum, heparin and bovine hypothalamic extract (Maciag et al., 1979) for infection and/or immunofluorescent staining. Infection with B. bacilliformis expressing green fluorescent protein was performed as described previously (Verma et al., 2000; .
Immunofluorescence staining for filopodia and membrane ruffles
Infection was terminated at selected time points by several washes of PBS, and subsequently cells were fixed with 4% paraformaldehyde in PBS for 30 min at room temperature. Cells were washed several times with PBS, post fixation. Uninfected and infected monolayers on glass cover slips were blocked with two washes of Tris-glycine buffer and the cells were permeabilized with 0.5% Triton X-100 for 15 min. Cover slips were then blocked overnight at 4°C in PBS containing 0.1% Triton X-100, 1% BSA, 1% normal rabbit serum and 0.2% sodium azide. After overnight incubation, primary antibody was added to the same solution and incubated for 1 h at room temperature. Cover slips were washed three times with PBS and further incubated with secondary antibody (rabbit anti-mouse IgG-TRITC) and/or stained with F-actin phalloidin fluorescein (0.1 µg ml −1 ) for 30 min to visualize filopodia and lamellipodia/membrane ruffles. Cover slips were again washed with PBS and mounted on the slides using a fluorescent mounting medium (DAKO) and fluorescent images were captured in Axiophot II digital imaging system in the Imaging Analysis Laboratory. The brightness and contrast of each image were identically modified in Adobe Photoshop 5.0.
GST-PBD expression and affinity precipitation of activated Rac and Cdc42
The pGEX expression vector containing PBD (p21-activated kinase putative binding domain for Rac1/Cdc42), kindly provided by Jorge E. Gálan (Yale University) was expressed in E. coli and GST fusion protein was purified by glutathione-sepharose affinity chromatography as described (Bagrodia et al., 1995a) . Briefly, expression of GST-PBD was induced with 1 mM IPTG and lysed in 80 ml of ice cold PBS containing 1 mg ml −1 lysozyme, 1% Triton X-100, 25% sucrose, 1 mM EDTA, 5 mM β-mercaptoethanol, 1 mM phenylmethylsulphonyl fluoride (PMSF) for 30 min on ice with occasional shaking. The slurry was then passed through a French press and centrifuged at 10 000 g for 10 min at 4°C. The lysate was added to washed glutathione-agarose beads (Pharmacia Biotechnology) and mixed gently at 4°C for 1 h. The beads were centrifuged at 500 g for 5 min, washed four times with PBS containing 1% Triton X-100 and washed three times with 50 mM Tris2-HCl (pH 7.5), 150 mM NaCl and resuspended in the same buffer. Affinity precipitation of cellular activated Rac and Cdc42 (GTP-bound forms) were performed as described (Bernard et al., 1999) . Briefly, endothelial cells infected with B. bacilliformis for different time periods were scraped and resuspended in lysis buffer (10 mM Tris-Cl pH 7.4, 150 mM NaCl, 1 mM DTT, 1 mM EDTA, 1 mM EGTA, 1% Nonidet P-40, 1 mM orthovandate, 1 mM PMSF, 50 mM NaF, 10 µg ml −1 leupeptin and 1 µg ml −1 pepstatin) and left for 30 min on ice. Lysates were clarified by centrifugation at 16 000 g and protein content in the lysates was estimated (Bradford, 1976) . Equal amounts (300 µg) of the endothelial cell protein lysates from infected and uninfected cells were incubated for 1 h at 4°C with 50 µg of GST-PBD beads to capture activated Rac/Cdc42. The beads were then washed four times with wash buffer (50 mM Tris pH 7.5, 0.5% Nonidet P-40, 50 mM NaCl, 30 mM MgCl 2 , 1 mM DTT, 10 µg ml −1 each of leupeptin and aprotinin and 1 mM PMSF). Proteins were eluted by boiling for 3-5 min in 1 × SDS sample buffer and separated on SDS-PAGE and transferred onto the Hybond ECL nitrocellulose membrane, and blotted sequentially with the anti-Rac and anti-Cdc42 mouse monoclonal antibodies and detected with the secondary antibody conjugated with horseradish peroxidase (HRP) using enhanced chemiluminescence. For quantitative analysis, films were scanned by densitometry using an AlphaImager 2000 (Alpha Innotech, San Leandro, CA). To determine levels of total-Rac and Cdc42 in lysates prepared at different time intervals of infection, equal amounts of protein was loaded on SDS-PAGE and analysed by Western blotting using anti-Rac and anti-Cdc42 antibodies. To confirm the equal loading of the proteins the membrane was stripped and then blotted with the anti-GAPDH monoclonal antibodies.
Immunoprecipitation and kinase activity of PAK
Uninfected and infected endothelial cells (2, 12 or 24 h) were lysed in 1 ml of ice-cold lysis buffer (10 mM Tris-Cl pH 7.6, 50 mM NaCl, 5 mM EDTA, 30 mM sodium pyrophosphate, 1 mM orthovandate, 1% NP-40, 50 mM NaF, 10 µg ml −1 leupeptin, 1 µg ml −1 pepstatin and 1 mM PMSF). Lysates were clarified by centrifugation at 16 000 g for 10 min. Total cell lysates were precleared with normal rabbit IgG together with the protein Aagarose. Endogenous PAK was immunoprecipitated from 250 µg lysates from the uninfected and infected endothelial cell from different times of infection with anti-PAK1 antibody (Rabbit polyclonal anti-PAK1 (N-20), Santa Cruz Biotechnology) using the protein A-agarose beads. After capturing, the beads were washed four times with lysis buffer and three times with the kinase buffer, 50 mM HEPES (pH 7.5), 10 mM MgCl 2 10 mM MnCl 2 , and 0.2 mM DTT and finally resuspended in 20 µl of the kinase buffer. Kinase activity in immunocomplex was determined using an in vitro kinase assay as described previously . Briefly, the beads were incubated in the kinase buffer with 50 µCi of [γ-32 P]-ATP, 100 µM cold ATP and 0.5 mg ml −1 of myelin basic protein for 20 min at 30°C. The reaction was stooped by the addition of SDS-PAGE buffer and boiling for 5 min. The samples were separated on 12% SDS-PAGE, dried and autoradiographed, films were scanned by densitometry using an AlphaImager 2000 (Alpha Innotech, San Leandro, CA).
In vivo glucosylation with TcdB-10463 and TcsL-1522 Endothelial cells (HUVECs) were grown in 96-well plates to a subconfluent density. Clostridium difficile toxin B, TcdB-10463 and C. sordellii LT toxin, TcsL-1522 were diluted serial-fold to determine the cytotoxicity dose and the time of the incubation required for the rounding of the cells. A concentration of 1 µg ml −1 was used for TcdB-10463 for 1, 2, 3 and 4 h to achieve approximately 100% of rounding of the endothelial cells. A concentration of 100 ng ml −1 of LT toxin, TcsL-1522 was used 4, 8, 12, 16 and 24 h to achieve approximately 100% of rounding of the endothelial cells. Flow cytometry to access the affect of inactivation of Rho-GTPases by Clostridial toxins, TcdB-10463 and TcSL-1522 on internalization of B. bacilliformis was performed as described previously (Verma et al., 2001) . Extent of in vivo glucosylation of small GTP-binding proteins with toxin B and LT was determined by in vitro glucosylation.
In vitro glucosylation with TcdB-10463 and TcsL-1522 After indicated incubations with toxin B and LT, the cells were removed from the plates with a rubber policeman and washed with PBS followed by centrifugation. Washing with PBS was repeated at least three times to remove residual toxins and, finally, cell pellets were resuspended in 50 µl of glucosylation buffer (50 mM triethanolamine HCl buffer (pH 7.5) containing 2 mM MgCl 2 , 150 mM KCl, 100 µM dithiothreitol and 5 mM GDP, 1 µg ml −1 leupeptin and 1 µg ml −1 pepstatin). Cells were then lysed with a brief sonication and the amount of protein in each cell lysate was estimated. In vitro glucosylation was performed as described . Briefly, equal amounts of the endothelial cell lysates in glucosylation buffer were added to 20 µl of dried UDP-[ ; DuPont NEN) with 20 µg ml −1 of toxin B and 10 µg ml −1 LT. This mixture was incubated for 1 h at 37°C. For in vitro glucosylation with LT, glucosylation buffer was supplemented with 1 mM MnCl 2 . The reactions were terminated by addition of Laemmli sample buffer and electrophoresed on a 15% SDS-polyacrylamide gel. The gels were stained, destained, dried and analysed for radioactivity by autoradiography.
Electrophoretic mobility shift assay
Monolayers of uninfected and infected endothelial cells for various time intervals were washed several times with cold PBS. Nuclear extracts were prepared as described by Mounier et al. (1999) . Cells were scraped and harvested by centrifugation for 1 m at 2000 g, rinsed with cold PBS. Cells were resuspended in Buffer A (10 mM HEPES, pH 8.0 1.5 mM MgCl 2 , 10 mM KCl, 0.5 mM dithiothreitol, 300 mM sucrose 0.1% nonidet P-40, 1 µg ml −1 leupeptin, 1 µg ml −1 pepstatin and 0.5 mM PMSF) and left on ice for 5 min. The crude nuclear pellet was isolated by a pulsed microcentrifugation and pellet was washed once with the buffer A and resuspended in buffer B (20 mM HEPES, pH 8.0 20% glycerol, 100 mM KCl, 100 mM NaCl, 0.2 mM EDTA, 0.5 mM dithiothreitol, 1 µg ml −1 leupeptin, 1 µg ml −1 pepstatin and 0.5 mM PMSF. Nuclei were sonicated for 10 s and clarified by pulsed centrifugation to prepare nuclear extracts. Electrophoretic mobility shift assay for the detection of AP-1 activity in nuclear extracts was performed using gel shift assay systems from Promega (Promega, USA). Oligonucleotides containing the AP-1 binding site: 5′-CGCTTGATGAGTCAGCCGGAA-3′ was used. The AP-1 DNA binding oligonucleotide was labeled using T4 kinase in the presence of [γ-32 P]-ATP. DNA binding reactions were performed with endothelial cell nuclear extracts using a binding buffer containing 10 mM Tris, pH 7.5, 2.5 µg of poly (dIdC), 1 mM MgCl 2 , 50 mM NaCl, 0.5 mM EDTA, 0.5 mM DTT, 5% glycerol and labelled AP-1 oligonucleotide as a probe. For competition experiments cold AP-1 and NF-kB oligonucleotides were used in 100-fold excess as specific and non-specific competitors respectively. The reaction products were analysed by electrophoresis in a 6% non-denaturing polyacrylamide gel using 12.5 mM Tris, 12.5 mM boric acid and 0.25 mM EDTA, pH 8.3. The gels were dried and exposed to Kodak films at −70°C using an intensifying screen. Quantification and densitometric analysis of gel shift assays was performed on Phosphoimager.
Western blotting with MAPKs
Monolayers of uninfected and infected endothelial cells for various time intervals were washed several times with cold PBS. Cells were scraped and harvested by centrifugation for 1 min at 2000 g, rinsed with cold PBS. For the preparation of the total extracts of the endothelial cells, harvested pellets were resuspended in Buffer A (10 mM HEPES, pH 8.0 1.5 mM MgCl 2 , 10 mM KCl, 0.5 mM dithiothreitol, 300 mM sucrose 0.1% nonidet P-40, 1 µg ml −1 leupeptin, 1 µg ml −1 pepstatin and 0.5 mM PMSF) and sonicated to ensure the lysis of nuclei. Sonicated lysate was centrifuged at 16 000 g for 5 min and the supernatents were used for the Western blotting with the MAPKs. Blots prepared with total extracts of the infected endothelial cells were first probed with the MAPKs specifically recognizing the phosphorylated form of MAPKs and detected using enhanced chemiluminescence detection system. Blots were stripped and then probed either with the antibodies recognizing total MAPKs or with GAPDH to confirm equal loadings. All the MAPKs antibodies were from NEB and used with the dilutions recommended by the manufacturer.
